IHC assay shown that C14orf166 was primarily localized in the tumor cell nuclei (Fig. 2), and its expression was positively correlated with advancing clinical stage (Fig. 2), Taken together, these results suggested C14orf166 expression increased with advancing clinical stage in breast cancer. Here, RTRAF is linked to breast carcinoma.